Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
International Immunopharmacology
|
March 28, 2024
Pharmacological blockade of HDAC6 attenuates cancer progression by inhibiting IL-1β and modulating immunosuppressive response in OSCC
Ashutosh Mahale, Ganesh Routholla, S Lavanya, et al.
International Immunopharmacology
|
June 19, 2022
HDAC6 inhibition attenuates renal injury by reducing IL-1β secretion and RIP kinase mediated necroptosis in acute oxalate nephropathy
Kavitha Sedmaki, Kalyani Karnam, Pravesh Sharma, et al.
Journal of Medicinal Chemistry
|
September 3, 2023
Selective HDAC3 Inhibitors with Potent In Vivo Antitumor Efficacy against Triple-Negative Breast Cancer
Sravani Pulya, Ambati Himaja, Milan Paul, et al.
Bioorganic Chemistry
|
June 13, 2021
Synthesis, biological evaluation, and molecular docking analysis of novel linker-less benzamide based potent and selective HDAC3 inhibitors
Ganesh Routholla, Sravani Pulya, Tarun Patel, et al.
European Journal of Medicinal Chemistry
|
May 31, 2022
Selective inhibition of histone deacetylase 3 by novel hydrazide based small molecules as therapeutic intervention for the treatment of cancer
Sravani Pulya, Tarun Patel, Milan Paul, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
July 27, 2020
HDAC6 inhibitor accelerates wound healing by inhibiting tubulin mediated IL-1β secretion in diabetic mice
Kalyani Karnam, Kavitha Sedmaki, Pravesh Sharma, et al.
European Journal of Medicinal Chemistry
|
April 23, 2025
Design and synthesis of pyridine-based benzamides as potent HDAC3 inhibitors as an armament against breast cancer with in vivo validation
Ambati Himaja, Ganesh Routholla, Tarun Patel, et al.
ACS Chemical Neuroscience
|
February 12, 2021
PT3: A Novel Benzamide Class Histone Deacetylase 3 Inhibitor Improves Learning and Memory in Novel Object Recognition Mouse Model
Sravani Pulya, Ashutosh Mahale, Yamini Bobde, et al.
Bioorganic Chemistry
|
October 30, 2021
Design, synthesis and binding mode of interaction of novel small molecule o-hydroxy benzamides as HDAC3-selective inhibitors with promising antitumor effects in 4T1-Luc breast cancer xenograft model
Ganesh Routholla, Sravani Pulya, Tarun Patel, et al.
ACS Medicinal Chemistry Letters
|
December 17, 2025
Ready Access to Benzodiazocines from Tryptamines: A Druggable Scaffold toward Antiviral Agents
N Sathya Sai Saranya, Rahul Choudhury, Ganesh Routholla, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
International Immunopharmacology
|
March 28, 2024
Pharmacological blockade of HDAC6 attenuates cancer progression by inhibiting IL-1β and modulating immunosuppressive response in OSCC
Ashutosh Mahale, Ganesh Routholla, S Lavanya, et al.
International Immunopharmacology
|
June 19, 2022
HDAC6 inhibition attenuates renal injury by reducing IL-1β secretion and RIP kinase mediated necroptosis in acute oxalate nephropathy
Kavitha Sedmaki, Kalyani Karnam, Pravesh Sharma, et al.
Journal of Medicinal Chemistry
|
September 3, 2023
Selective HDAC3 Inhibitors with Potent In Vivo Antitumor Efficacy against Triple-Negative Breast Cancer
Sravani Pulya, Ambati Himaja, Milan Paul, et al.
Bioorganic Chemistry
|
June 13, 2021
Synthesis, biological evaluation, and molecular docking analysis of novel linker-less benzamide based potent and selective HDAC3 inhibitors
Ganesh Routholla, Sravani Pulya, Tarun Patel, et al.
European Journal of Medicinal Chemistry
|
May 31, 2022
Selective inhibition of histone deacetylase 3 by novel hydrazide based small molecules as therapeutic intervention for the treatment of cancer
Sravani Pulya, Tarun Patel, Milan Paul, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
July 27, 2020
HDAC6 inhibitor accelerates wound healing by inhibiting tubulin mediated IL-1β secretion in diabetic mice
Kalyani Karnam, Kavitha Sedmaki, Pravesh Sharma, et al.
European Journal of Medicinal Chemistry
|
April 23, 2025
Design and synthesis of pyridine-based benzamides as potent HDAC3 inhibitors as an armament against breast cancer with in vivo validation
Ambati Himaja, Ganesh Routholla, Tarun Patel, et al.
ACS Chemical Neuroscience
|
February 12, 2021
PT3: A Novel Benzamide Class Histone Deacetylase 3 Inhibitor Improves Learning and Memory in Novel Object Recognition Mouse Model
Sravani Pulya, Ashutosh Mahale, Yamini Bobde, et al.
Bioorganic Chemistry
|
October 30, 2021
Design, synthesis and binding mode of interaction of novel small molecule o-hydroxy benzamides as HDAC3-selective inhibitors with promising antitumor effects in 4T1-Luc breast cancer xenograft model
Ganesh Routholla, Sravani Pulya, Tarun Patel, et al.
ACS Medicinal Chemistry Letters
|
December 17, 2025
Ready Access to Benzodiazocines from Tryptamines: A Druggable Scaffold toward Antiviral Agents
N Sathya Sai Saranya, Rahul Choudhury, Ganesh Routholla, et al.
Page
of 2